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Escherichia coli bacterioferritin was serendipitously crystallized in a novel cubic
crystal form and its structure could be determined to 2.5 A˚ resolution despite a
high degree of merohedral twinning. This is the first report of crystallographic
data on ‘as-isolated’ E. coli bacterioferritin. The ferroxidase active site contains
positive difference density consistent with two metal ions that had co-purified
with the protein. X-ray fluorescence studies suggest that the metal composition
is different from that of previous structures and is a mix of zinc and native iron
ions. The ferroxidase-centre configuration displays a similar flexibility as
previously noted for other bacterioferritins.
1. Introduction
Bacterioferritins are bacterial iron-storage proteins that play an
important role in the bacteria’s ability to utilize this element. They
are hollow protein shells made up of 24 subunits and are members of
the broad ferritin family. The iron is stored within the large cavity
inside the protein shell as a mineral core of hydrated ferric oxide and
phosphate. (Bacterio)ferritins generate the ferric form of iron by
catalysing the oxidation of soluble FeII into its insoluble FeIII form by
molecular oxygen. The so-called ferroxidase centre, a dinuclear iron
site, plays an important role in this iron-oxidation and mineralization
process, although the mechanistic details of its involvement may
differ between ferritins and bacterioferritins (Lewin et al., 2005).
Pores in the protein-shell subunit interfaces have been identified as
potential routes of ion flow to and from the cavity, but the mechan-
isms of specific iron uptake and release in (bacterio)ferritins remain
disputed. Even more obscure is the way the cell can regulate the
accumulation and utilization of its iron (Andrews et al., 2003) and
there may well be differences in regulatory control between different
organisms.
Escherichia coli bacterioferritin was the first bacterioferritin to
have its crystal structure determined (Frolow et al., 1994; Dautant et
al., 1998). This structure showed that each four-helix bundle subunit
has one catalytic ferroxidase centre consisting of a dinuclear metal
site, which contains two Fe atoms in vivo (Lewin et al., 2005). In
addition, bacterioferritins contain a haem which is sandwiched
between two subunits related by twofold symmetry (Carrondo, 2003).
Its function is not clear, but its reduction potential could allow it to
play a mediating role in electron transfer during reduction and
release of iron (Andrews et al., 2003). In vivo, bacterioferritin may
therefore contain iron at three distinct locations: haem iron, iron
from the ferroxidase centre and iron from the mineral core.
Mainly based on kinetic studies with E. coli bacterioferritin, a
three-stage model was proposed for iron uptake in which the
ferroxidase site plays a key role: (i) binding of two iron(II) ions per
ferroxidase centre, (ii) rapid oxidation of these iron(II) ions to
iron(III) by dioxygen and (iii) ferroxidase-dependent core formation
(Lewin et al., 2005). However, the exact mechanism by which core
formation depends on the ferroxidase site is not clear (Carrondo,
2003; Lewin et al., 2005). Two models have been proposed, one in
which iron(III) ions transit from the ferroxidase centre into the inner
cavity where they initiate or sustain core formation (Carrondo, 2003)
and an alternative model in which iron(II) ions inside the cavity are
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oxidized and nucleated, coupled with the simultaneous reduction of
iron(III) at the ferroxidase centre (Lewin et al., 2005). However,
comparison of these models with the structure of E. coli bacterio-
ferritin is confounded by the lack of crystallographic data on the iron-
bound state of the ferroxidase site. All crystal forms of this
bacterioferritin that have so far been obtained contain MnII from the
crystallization solution (Frolow et al., 1994; Dautant et al., 1998). The
different oxidation states of the ferroxidase centre have been char-
acterized by X-ray crystallography in the bacterioferritins of the
anaerobic sulfate-reducing bacterium Desulfovibrio desulfuricans
(Macedo et al., 2003) and the nitrogen-fixing bacterium Azotobacter
vinelandii (Swartz et al., 2006). These showed structural differences
around the ferroxidase centre, which have generated some contro-
versy about the mechanism by which ferroxidase activity is coupled to
core formation.
Here, we report the serendipitous discovery of crystals of an at first
unknown protein and the methods employed to simultaneously
determine both its identity as E. coli bacterioferritin as well as its
crystal structure. These crystals of ‘as-isolated’ E. coli bacterioferritin
have a new crystal form. X-ray fluorescence studies have been
performed to analyse the metal-ion content of this bacterioferritin.
2. Materials and methods
Crystal screens were performed with a recombinant Sulfolobus
acidocaldarius 2-keto-3-deoxygluconate aldolase preparation puri-
fied from an E. coli BL21(DE3) culture grown in Luria–Bertani
medium. The details of the expression, purification and structure
determination of this aldolase will be published elsewhere
(Wolterink-van Loo et al., manuscript in preparation). Briefly, crystals
were obtained at 291 K using the hanging-drop vapour-diffusion
technique, in which 1 ml of protein solution containing 18.9 mg ml1
aldolase and an unknown but low amount of impurities was mixed
with 1 ml reservoir solution containing 0.1M HEPES pH 7.5,
30%(v/v) PEG 400 and 0.2M MgCl2.
SDS–PAGE samples of crystals were prepared by washing the
crystals with reservoir solution and then dissolving them in SDS–
PAGE loading buffer. The samples were then applied onto a 20%
Phast gel (Amersham Pharmacia Biotech). Silver staining was
performed with a modification of the recommended protocol
(Amersham Pharmacia Biotech) in which the silver nitrate concen-
tration was doubled to 0.5% and the gel was stained twice.
X-ray diffraction data were collected at beamline ID14-2 (ESRF,
France). Data (Table 1) were processed using MOSFLM (Leslie,
1992) and programs from the CCP4 package (Collaborative
Computational Project, Number 4, 1994). Twinning was analysed with
the program DETWIN (Collaborative Computational Project,
Number 4, 1994). Molecular replacement was performed with Phaser
(McCoy et al., 2005) using two subunits of E. coli bacterioferritin
(PDB code 1bcf) as a search model. The data were subsequently
transformed into ideally twinned data by averaging the twin-related
intensities and an electron-density map was calculated with CNS
(Bru¨nger et al., 1998) using the scripts for perfectly twinned data. To
allow cross-validation of the model despite the twinning and eightfold
noncrystallographic symmetry (NCS), test-set reflections were
selected in thin resolution shells. Model bias was removed using the
simulated-annealing protocol in CNS (Bru¨nger et al., 1998) and minor
model rebuilding and placement of metal ions was performed in Coot
(Emsley & Cowtan, 2004). The data were subsequently detwinned
using the appropriate CNS scripts to allow final refinement with a
maximum-likelihood target function, which was performed with
REFMAC5 (Murshudov et al., 1999). Eightfold NCS restraints were
applied on the bacterioferritin polypeptide chains throughout
refinement; however, no NCS restraints were applied to the residues
making up the ferroxidase sites.
The X-ray absorption edges of Mn, Fe, Cu and Zn were scanned at
beamline BM16 (ESRF, France) and measured with a Roentec Xflash
fluorescence detector using a narrow X-ray bandpass.
3. Results and discussion
3.1. Structure determination
During crystallization experiments on 2-keto-3-deoxygluconate
aldolase from S. acidocaldarius (Wolterink-van Loo et al., manuscript
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Data collection
Space group P213
Unit-cell parameter (A˚) 167.9
Resolution (A˚) 60–2.5 (2.64–2.50)
Wavelength (A˚) 0.934
Completeness (%) 99.8 (98.7)
Redundancy 7.5 (5.4)
Unique reflections 54566 (7807)
I/(I) 18.0 (4.4)
Rsym† (%) 11 (34)
Refinement
No. of atoms
Protein 10392
Haem 340
Ferroxidase-site metals 16
Water 98
R/Rfree‡ (%) 17.1/18.8
Average B factor (A˚2) 23
R.m.s. deviations
Bonds (A˚) 0.009
Angles () 1.2
Ramachandran plot§ (%)
Favoured 98.7
Allowed 0.7
Outliers 0.6
† Rsym =
P jI  hIij=P I, where I is the observed intensity and hIi is the average
intensity. ‡ R =
P
hkl

jFobsj  kjFcalcj

=
P
hkl jFobsj  100, where Fobs is the observed
structure factor and Fcalc is the calculated structure factor. Rfree is R calculated
with 10% of the data in thin resolution shells that were omitted from the
refinement. § According to values from Lovell et al. (2003). The outliers are Ile79 of
each chain.
Figure 1
(a) A cubic crystal of E. coli bacterioferritin (red) growing between large hexagonal
aldolase crystals; (b) silver-stained SDS–PAGE gel of washed crystals. Lane 1,
contents of red cubic crystal; lane 2, contents of hexagonal aldolase crystal.
Molecular-weight standards (in kDa) are indicated.
in preparation), small cubic crystals with a bright red colour were
observed with typical dimensions of 80  50  30 mm, appearing
several weeks after the much larger aldolase crystals had formed
(Fig. 1a). One of them was suitable for X-ray diffraction analysis and
diffracted to better than 2.5 A˚ using synchrotron radiation (Table 1).
The data were initially scaled in the P432 point group; however,
subsequent examination of the intensity statistics revealed the
possibility that this crystal was merohedrally twinned with a high
twinning fraction. The high symmetry of the P432 point group does
not permit merohedral twinning. Therefore, the true space group
would then have the lower P23 symmetry and the twinning operator
(k, h, l) would generate the additional apparent symmetry. Initial
molecular-replacement attempts with the aldolase structure (33 kDa;
Wolterink-van Loo et al., manuscript in preparation) failed. More-
over, SDS–PAGE analysis of dissolved crystals revealed that the
crystals were made up of a 20 kDa protein (Fig. 1b). This suggested
that the crystals were not formed of the aldolase. Instead, an
unknown red-coloured contaminating protein from the E. coli
expression host appeared to have crystallized, even though the
aldolase preparation had been highly purified (Wolterink-van Loo et
al., manuscript in preparation).
Before attempting to establish the identity of this protein by mass
spectrometry, the Protein Data Bank was screened for E. coli protein
structures of the approximate size of the unknown protein with a
haem prosthetic group, the presence of which was suggested by the
bright red colour of the crystals. E. coli bacterioferritin matched all of
these criteria, since it is a 18.5 kDa protein, contains haem groups and
in addition it is normally found as a 24-mer with 432 point symmetry
(Frolow et al., 1994; Dautant et al., 1998). Therefore, it was selected
for use in molecular replacement and the basic building block of the
bacterioferritin sphere, consisting of a haem group sandwiched by
two identical 18.5 kDa polypeptide chains, was used as a search
model. Indeed, it was possible to obtain a high-scoring solution in
space group P213. Despite the twinning, four of these dimers could be
located in one of the two twin domains and inspection of the resulting
electron-density maps revealed a very good fit of the model. The data
were subsequently detwinned and the model was refined to accep-
table R factors (Table 1). The good fit to the electron density over the
entire sequence and the low R factors firmly establish that these
crystals are formed of E. coli bacterioferritin.
3.2. The overall structure of bacterioferritin
E. coli bacterioferritin has previously been reported to form
diffraction-quality crystals in four different crystal forms (Dautant et
al., 1998). Here, bacterioferritin was identified in an additional cubic
crystal form with different crystal packing. In this crystal form, eight
of the polypeptide subunits of the 24-mer bacterioferritin shell (Fig. 2)
were found in the asymmetric unit; they show a high overall similarity
to the structures in space groups P21 and P42212 for which the
coordinates are publicly available (Dautant et al., 1998; Frolow et al.,
1994), as illustrated by the small r.m.s.d. of 0.4 A˚ between the 158 C
atoms of a subunit. No clearly preferred orientation of the asym-
metrical haem b in its symmetrical binding site is apparent, as there
were no clear density differences between the two possible locations
of the vinyl substituents. To represent this ambiguity, the two possible
orientations were modelled with half occupancy, analogous to what
has been found in the crystal structures of the Rhodobacter capsu-
latus, D. desulfuricans and A. vinelandii bacterioferritins (Cobessi et
al., 2002; Macedo et al., 2003; Swartz et al., 2006), but in contrast to the
high-resolution structures of the E. coli bacterioferritin in its tetra-
gonal crystal form, where a certain preference for one orientation was
observed (Frolow & Kalb, 2001). The bright red colour of the crystals
(Fig. 1a) had already indicated the presence of this haem and also
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Figure 2
Overall structure of E. coli bacterioferritin. (a) Cartoon representation of the eight subunits found in the asymmetric unit. Additional subunits generating the entire protein
shell are indicated as traces. (b) The bacterioferritin dimeric building block, consisting of two four-helix bundles. The short capping helices, which are involved in intersubunit
contacts, are rendered in a different colour. The haem group is in stick representation and spheres indicate the metal positions of the ferroxidase centre. Figs. 2 and 3 were
generated with PyMOL (DeLano Scientific; http://pymol.sourceforge.net/).
suggests the absence of an elaborate mineral core of ferric oxide,
which would have rendered the crystal darker.
3.3. The ferroxidase centre
A more significant difference is present in the ferroxidase centre.
Initial electron-density maps calculated with phases from the
previously solved E. coli bacterioferritin model with the Mn ions
removed showed the presence of positive difference density, char-
acteristic of two transition metal ions in the previously identified FE1
and FE2 sites (Fig. 3a). No Mn or other transition metals were added
to the buffers used for purification or crystallization (Wolterink-van
Loo et al., manuscript in preparation) and whereas divalent magne-
sium ions are present during crystallization, they could not account
for the observed density levels. The coordination of the metal ions is
quite similar to the MnII coordination in the previously determined
structures of E. coli bacterioferritin (Frolow & Kalb, 2001; Dautant et
al., 1998; Frolow et al., 1994). Glu18 and His54 act as ligands for site
FE1, while Glu94 and His130 are ligands for site FE2 and the two
glutamates Glu51 and Glu127 are bridging ligands (Figs. 3a and 3b).
The largest difference in coordination involves Glu18, which donates
both of its carboxylate O atoms as ligands to site FE1 in this structure,
whereas in the Mn-occupied structures it acts as a monodentate
ligand. As a result, the metal in site FE1 has five protein-derived
ligands, whereas the metal occupying site FE2 has only four.
Although the positions of atoms forming the ferroxidase sites were
refined without applying NCS restraints, they do not show dramatic
differences between the eight crystallographically independent
molecules. Some residual density at 2.4 A˚ from the FE2 site is
present in four out of eight of the independent ferroxidase sites in the
asymmetric unit, which probably indicates an additional water ligand.
A distance of 3.76 A˚ (range 3.53–3.92 A˚) separates the two ions on
average, which is clearly shorter than the average 4.0–4.3 A˚ Mn–Mn
distances in previous structures (Dautant et al., 1998; Frolow et al.,
1994), also supporting a different identity for these two ions.
To ascertain the identity of the metal ions in the structure, X-ray
fluorescence spectra were recorded on a bacterioferritin crystal
around the iron, manganese, copper and zinc K absorption edges
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Figure 3
The ferroxidase centre. (a) Stereo figures of A-weighted Fo  Fc density in the ferroxidase site contoured at 5, (b) superposition of the ferroxidase centre of the P213
structure (grey/orange) and the Mn-bound structure (yellow/purple; PDB code 1bcf; Frolow et al., 1994) of E. coli bacterioferritin and (c) superposition of the FE2 site
environment in the P213 E. coli bacterioferritin structure (grey) with the corresponding region in the structure of reduced A. vinelandii bacterioferritin (pale green; PDB
code 1fkz; Swartz et al., 2006). The location of the inner cavity (IC) is indicated. This view is rotated 90 with respect to the previous views.
(Fig. 4). These spectra indicated the presence of iron and also zinc,
whereas manganese and copper were absent. Diffraction data
collected around the Zn and Fe K edges would have unambiguously
determined the specific location of the different metal ions at the
centre, but none of the 25 crystals we tested were of sufficient
quality to allow measurement of anomalous differences. Never-
theless, the X-ray fluorescence spectra do give some indication of the
relative amount of metal ions present. The fluorescence signal,
corrected for beam intensity, was weaker for zinc than for iron, even
though zinc has a close to twofold larger fluorescence intensity than
iron (Shi et al., 2005). Cautious estimation would then suggest the
presence of more than twice as much iron than zinc in the bacterio-
ferritin structure. Since the ferroxidase centre of E. coli bacterio-
ferritin can bind zinc with higher affinity than iron (Baaghil et al.,
2003; Le Brun et al., 1995), the zinc that was detected probably partly
substituted iron at the ferroxidase sites. In agreement with this, the
iron X-ray fluorescence spectrum has an irregular shape, indicating
the presence of iron in multiple chemically different environments.
This suggests that the signal of iron is not only derived from the haem
b, but also from iron at the ferroxidase centre sites and perhaps from
some ferric ions bound in the inner cavity that remained undetected
in the crystallographic analysis.
The diffraction data were then re-examined with the knowledge
that the ferroxidase FE1 and FE2 sites may be occupied by zinc and/
or iron. The metal ions in the centre were modelled as either zinc or
iron, but refinement did not lead to significant differences in co-
ordination geometry, electron-density features or R factors. This is
not entirely surprising since ZnII closely mimics FeII binding and has
been used as a model for FeII binding to similar dinuclear sites in
E. coli ferritin A (Stillman et al., 2001, 2003). The coordination
arrangements of the FE1 and FE2 sites (Fig. 3a) have been observed
for both iron as well as zinc coordination in protein and small-
molecule structures (Harding, 2000, 2006). The average distance
between a zinc and a monodentate glutamate ligand is 1.99 A˚, for
example, which is quite comparable to the corresponding value for
iron (2.03 A˚). This structural similarity between zinc and iron
therefore does not allow distinction between partial or complete
substitution of iron for zinc, but it follows that the present config-
uration should resemble the native iron-bound state.
3.4. Comparison with ferroxidase centres from other
bacterioferritins
Recent structural studies on D. desulfuricans and A. vinelandii
bacterioferritins have suggested that redox-dependent conforma-
tional changes occur at the ferroxidase centre, consistent with
transfer of iron from the ferroxidase centre to the interior (Macedo et
al., 2003; Swartz et al., 2006). The occupancy of the metal sites and the
flexibility at and around the ferroxidase centre in the current E. coli
bacterioferritin structure were therefore analysed. All independent
subunits display density for site FE1 of a level comparable to the
density of the Fe atoms in the haem groups, indicating full occupancy,
whereas the FE2 site is only partly occupied (estimated at 75%). This
situation is very similar to the two independently determined
homologous A. vinelandii bacterioferritin structures (66% sequence
identity, average r.m.s.d. of 0.5 A˚ between 155 matching subunit C
atoms), where occupancy levels of FE2 were estimated at 50 and 80%
(reduced state), respectively (Liu et al., 2004; Swartz et al., 2006).
Furthermore, the FE2 site of E. coli bacterioferritin was reported to
have a lower affinity for MnII than the FE1 site (Frolow & Kalb,
2001). In all of these structures, the FE2 site therefore appears to
have somewhat reduced occupancy levels.
The lower affinity for MnII of the FE2 site in E. coli bacterioferritin
was attributed to the availability of an alternative conformation for
the His130 side chain (Frolow & Kalb, 2001). Also, the present
structure, obtained in the absence of Mn and from different condi-
tions, indicates some flexibility of His130 and in addition of Glu94
and the nearby Glu47 and Tyr25, as indicated by their comparatively
high B factors and electron-density features. Significantly, Glu47 and
Tyr25 in the E. coli bacterioferritin structures have conformations
that differ from the corresponding residues in the A. vinelandii
bacterioferritin structures (Fig. 3c). In E. coli bacterioferritin the
Tyr25 ring is rotated by about 70, while maintaining a hydrogen bond
with Glu94 as in the A. vinelandii bacterioferritin structures, whereas
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Figure 4
X-ray fluorescence scans around the K edges of Mn, Fe, Cu and Zn, as indicated. Plots are corrected for beam intensity and fluorescence is on an arbitrary scale.
the Glu47 carboxylate group points towards Tyr25 and makes an
additional hydrogen bond. Moreover, the oxidized and reduced states
of the A. vinelandii bacterioferritin display conformational variability
for the His130, Glu94 and Glu47 side chains (Swartz et al., 2006).
Given the high structural conservation between the ferroxidase
centres and their environment between A. vinelandii and E. coli
bacterioferritins, the conformations observed in the various A. vine-
landii bacterioferritin structures for the side chains of His130, Glu47,
Glu94 and Tyr25 may also be accessible for E. coli bacterioferritin
(Fig. 3c).
Such conformational changes could point to an iron-transfer
mechanism from site FE2 towards the inner cavity (Swartz et al.,
2006). However, the details of how such a mechanism would take
place are not clear. The observed flexibility and conformational
changes per se do not change the fact that the FE2 sites in E. coli and
A. vinelandii bacterioferritins remain favourable binding sites for
iron in either of its oxidation states. High-affinity binding of FeIII to
the FE2 site is also consistent with spectroscopic data on recon-
stituted iron-loaded E. coli bacterioferritin. These suggested that the
ferroxidase centre of bacterioferritins is stable and FeIII ions do not
leave the ferroxidase centre upon oxidation (Yang et al., 2000).
Indeed, cycling between the reduced and oxidized states of A. vine-
landii bacterioferritin did not result in emptying of one or both sites
of the ferroxidase centre (Swartz et al., 2006), which is inconsistent
with a straightforward iron-transfer mechanism. Therefore, the
structural data do not reveal how transfer of oxidized iron from the
ferroxidase centre to the inner cavity could be the main determinant
of the growth of the mineral core.
The available data also allow other interpretations for conforma-
tional changes at this location. Some flexibility may only be required
to allow initial occupation of the ferroxidase centre. Also, the
conformational changes may play a role in the alternative core-
formation mechanism involving electron transfer from the cavity to
the ferroxidase centre. As noted by Liu et al. (2004), some inherent
flexibility around the FE2 site is necessary to accommodate iron in its
different oxidation states. Different positions of key residues may
also alter the electrostatic properties of the underlying surface of the
inner cavity and promote initial nucleation of the core or favour
electron transfer from the core to the ferroxidase centre.
Swartz et al. (2006) also observed conformational differences
between oxidized and reduced forms of A. vinelandii bacterioferritin
for some side chains of residues leading from the ferroxidase centre
to a pore on the threefold subunit interface in some of their crys-
tallographically independent molecules. On the basis of this, a general
redox-dependent signalling mechanism for ferritins between the
ferroxidase centre and the threefold pore was suggested. Regarding
this, we note that many of the residues proposed to be involved in this
signalling mechanism are not conserved in the highly homologous
E. coli bacterioferritin; A. vinelandii bacterioferritin residues Ser126,
Glu129, Glu121 and Glu118 are Asp, Gly, Ile and Glu, respectively, in
E. coli bacterioferritin, making such a general signalling mechanism
highly unlikely.
4. Conclusion
A structure of the E. coli bacterioferritin has been serendipitously
obtained in a novel crystal form. Of the five bacterioferritin crystal
structures known to date, three have been determined after crystals
were unintentionally obtained (this study; Cobessi et al., 2002; Zhao et
al., 2004). This highlights the ease of crystallization of proteins with
this architecture. In vivo, crystallization of human ferritin has even
been implicated in disease (Brooks et al., 2002). The structure of the
‘as isolated’ E. coli bacterioferritin that we have obtained in this
fortuitous way has a different metal content to previous E. coli
bacterioferritin structures, with an undefined mix of zinc and native
iron ions occupying the ferroxidase centre. Flexibility of residues
around the FE2 iron site appears to be a general feature of this type
of bacterioferritins, whose function remains ill-defined.
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